Abstract:In the first part, the following mechanisms involved in different forms of cell death are considered, with a view to identifying potential therapeutic targets: tumour necrosis factor receptors (TNFRs) and their engagement by tumour necrosis factor-alpha (TNF-α); poly [ADP-ribose] polymerase (PARP)-1 cleavage; the apoptosis signalling kinase (ASK)-c-Jun N-terminal kinase (JNK) axis; lysosomal permeability; activation of programmed necrotic cell death; oxidative stress, caspase-3 inhibition and parthanatos; activation of inflammasomes by reactive oxygen species and the development of pyroptosis; oxidative stress, calcium dyshomeostasis and iron in the development of lysosomal-mediated necrosis and lysosomal membrane permeability; and oxidative stress, lipid peroxidation, iron dyshomeostasis and ferroptosis. In the second part, there is a consideration of the role of lethal and sub-lethal activation of these pathways in the pathogenesis and pathophysiology of neurodegenerative and neuroprogressive disorders, with particular reference to the TNF-α-TNFR signalling axis; dysregulation of ASK-1-JNK signalling; prolonged or chronic PARP-1 activation; the role of pyroptosis and chronic inflammasome activation; and the roles of lysosomal permeabilisation, necroptosis and ferroptosis. Finally, it is suggested that, in addition to targeting oxidative stress and inflammatory processes generally, neuropsychiatric disorders may respond to therapeutic targeting of TNF-α, PARP-1, the Nod-like receptor NLRP3 inflammasome and the necrosomal molecular switch receptor-interacting protein kinase-3, since their widespread activation can drive and/or exacerbate peripheral inflammation and neuroinflammation even in the absence of cell death. To this end, the use is proposed of a combination of the tetracycline derivative minocycline and N-acetylcysteine as adjunctive treatment for a range of neuropsychiatric disorders.

Cell death pathways: intricate connections and disease implications

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

The therapeutic potential of targeting regulated non-apoptotic cell death

Types of Cell Death from a Molecular Perspective

The molecular relationships between apoptosis, autophagy and necroptosis

Navigating the complexities of cell death: Insights into accidental and programmed cell death

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Different types of cell death and their shift in shaping disease

Multiple forms of cell death: A focus on the PI3K/AKT pathway

Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis

Cell death pathologies: targeting death pathways and the immune system for cancer therapy

Deciphering the Molecular Nexus: an In-Depth Review of Mitochondrial Pathways and Their Role in Cell Death Crosstalk

Paraptosis—A Distinct Pathway to Cell Death

Emerging connectivity of programmed cell death pathways and its physiological implications

The molecular machinery of regulated cell death

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

The romantic history of signaling pathway discovery in cell death: an updated review

Cell death-mediated cytokine release and its therapeutic implications

Regulated cell death: discovery, features and implications for neurodegenerative diseases